Healthcare Services

Lisinopril Market Analysis Focusing on Growth Potential and Future Outlook

April 23, 2026April 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Lisinopril Market Expected To Reach Based On Its 2026 Value?

The lisinopril market size has demonstrated robust growth over recent years. It is anticipated to expand from $1.87 billion in 2025 to $1.99 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.2%. The expansion observed in the historic period can be attributed to several factors, including the increasing incidence of hypertension, widespread clinical acceptance of ACE inhibitors, an expanding aging population, early adoption in heart failure treatment, and the broadening of primary healthcare access.

The lisinopril market is anticipated to experience robust expansion over the coming years. This market is projected to reach $2.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. The expansion during the outlook period is primarily driven by factors such as the increasing prevalence of cardiovascular diseases, a heightened need for economical generic medications, a greater emphasis on proactive cardiac health, the broadening of treatment options for diabetic kidney disease, and increased healthcare expenditure on managing chronic conditions. Key trends anticipated throughout this forecast encompass the escalating incidence of hypertension and various cardiovascular ailments, an increasing dependence on ACE inhibitors as initial treatment, a wider uptake of generic lisinopril prescriptions, its expanded application in post-myocardial infarction care, and improved long-term adherence to chronic care regimens.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

Which Strong Drivers Are Impacting The Lisinopril Market Growth?

The rising incidence of cardiovascular conditions is projected to drive the expansion of the lisinopril market in the future. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels. This increase in CVD prevalence stems from factors such as an expanding and aging population, various risk factors, and the inadequate application of established prevention and treatment methods. Lisinopril assists in controlling CVDs primarily by decreasing blood pressure and alleviating stress on the heart and kidneys. The medication achieves this by blocking angiotensin II production, promoting vasodilation, lowering blood volume, and safeguarding organs from harm. For example, in May 2024, the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, reported that ischemic heart diseases led to 5,302 deaths, indicating a slight increase from 5,290 deaths in 2022. Consequently, the growing prevalence of cardiovascular diseases is fueling the expansion of the lisinopril market.

Which Segment Types Are Examined In The Lisinopril Market Segment Study?

The lisinopril market covered in this report is segmented –

1) By Brand: Prinivil, Zestril, Other Brands

2) By Disease: Hypertension, Heart Failure, Heart Attack

3) By Dosage: Tablet, Liquid

4) By End-Users: Hospitals, Specialty Clinics

Subsegments:

1) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil

2) By Zestril: Different Dosage Forms, Generic Versions Of Zestril

3) By Other Brands: International Brand Variants, Combination Drug Formulations

Which Players Are Part Of The Competitive Landscape Of The Lisinopril Market?

Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zydus Cadila Healthcare Ltd., Hetero Ltd., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Mylan Pharmaceuticals Inc., Accord Healthcare Ltd., Sandoz International GmbH

Get The Full Lisinopril Market Report:

https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

Which Region Leads The Lisinopril Market In Terms Of Market Share?

North America was the largest region in the lisinopril market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lisinopril Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

Browse Through More Reports Similar to the Global Lisinopril Market 2026, By The Business Research Company

Liraglutide Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Lithium Market Report

https://www.thebusinessresearchcompany.com/report/lithium-global-market-report

Lithium Ion Li Ion Batteries Market Report

https://www.thebusinessresearchcompany.com/report/lithium-ion-li-ion-batteries-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795